These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2871467)

  • 21. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
    Urwyler S; Markstein R
    J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine D1 receptors characterized with [3H]SCH 23390. Solubilization of a guanine nucleotide-sensitive form of the receptor.
    Niznik HB; Otsuka NY; Dumbrille-Ross A; Grigoriadis D; Tirpak A; Seeman P
    J Biol Chem; 1986 Jun; 261(18):8397-406. PubMed ID: 3522568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Striatal D1- and D2-dopamine receptor sites are separately detectable in vivo.
    Leslie CA; Bennett JP
    Brain Res; 1987 Jul; 415(1):90-7. PubMed ID: 2957025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoradiographic localization of dopamine DA1 receptors in rat kidney with [3H]Sch 23390.
    Huo T; Healy DP
    Am J Physiol; 1989 Sep; 257(3 Pt 2):F414-23. PubMed ID: 2528915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological and biochemical characterization of the D-1 dopamine receptor mediating acetylcholine release in rabbit retina.
    Hensler JG; Cotterell DJ; Dubocovich ML
    J Pharmacol Exp Ther; 1987 Dec; 243(3):857-67. PubMed ID: 2961878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The D1 dopamine receptor in the rat brain: quantitative autoradiographic localization using an iodinated ligand.
    Dawson TM; Barone P; Sidhu A; Wamsley JK; Chase TN
    Neuroscience; 1988 Jul; 26(1):83-100. PubMed ID: 2971144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine D1 and D2 receptor selectivities of agonists and antagonists.
    Seeman P; Ulpian C
    Adv Exp Med Biol; 1988; 235():55-63. PubMed ID: 2976254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of [3H]SCH 23390 to D-1 receptors in the putamen of control and parkinsonian subjects.
    Raisman R; Cash R; Ruberg M; Javoy-Agid F; Agid Y
    Eur J Pharmacol; 1985 Jul; 113(3):467-8. PubMed ID: 2864270
    [No Abstract]   [Full Text] [Related]  

  • 29. Characterization of D1 dopamine receptors in the bovine pineal gland with [3H]SCH 23390.
    Simonneaux V; Murrin LC; Ebadi M
    J Pharmacol Exp Ther; 1990 Apr; 253(1):214-20. PubMed ID: 2139469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of radioiodinated TISCH: a high-affinity and selective ligand for mapping CNS D1 dopamine receptor.
    Billings JJ; Kung MP; Chumpradit S; Mozley D; Alavi A; Kung HF
    J Neurochem; 1992 Jan; 58(1):227-36. PubMed ID: 1530770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serotonergic component of SCH 23390: in vitro and in vivo binding analyses.
    McQuade RD; Ford D; Duffy RA; Chipkin RE; Iorio LC; Barnett A
    Life Sci; 1988; 43(23):1861-9. PubMed ID: 2904635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the rat.
    Graham WC; Crossman AR; Woodruff GN
    Brain Res; 1990 Apr; 514(1):93-102. PubMed ID: 2113410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of the selectivities of SCH 23390 with BW737C89 for D1, D2 and 5-HT2 binding sites both in vitro and in vivo.
    Riddall DR
    Eur J Pharmacol; 1992 Jan; 210(3):279-84. PubMed ID: 1351844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the binding of SCH 39166 to the five cloned dopamine receptor subtypes.
    Tice MA; Hashemi T; Taylor LA; Duffy RA; McQuade RD
    Pharmacol Biochem Behav; 1994 Nov; 49(3):567-71. PubMed ID: 7862709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo binding to dopamine receptors: a correlate of potential antipsychotic activity.
    McQuade RD; Duffy RA; Coffin VL; Barnett A
    Eur J Pharmacol; 1992 Apr; 215(1):29-34. PubMed ID: 1355442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The kinetics of [3H]SCH 23390 dissociation from rat striatal dopamine D1 receptors: effect of dopamine.
    Farrell CB; O'Boyle KM
    Eur J Pharmacol; 1994 Jun; 268(1):79-88. PubMed ID: 7925614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of [125I]SCH 23982 binding in human brain: comparison with [3H]SCH 23390.
    Laruelle M; Sidhu A; Casanova MF; Weinberger DR; Kleinman JE
    Neurosci Lett; 1991 Oct; 131(2):273-6. PubMed ID: 1837073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of novel fluorescent ligands with high affinity for D1 and D2 dopaminergic receptors.
    Monsma FJ; Barton AC; Kang HC; Brassard DL; Haugland RP; Sibley DR
    J Neurochem; 1989 May; 52(5):1641-4. PubMed ID: 2523470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [3H]Fluphenazine binding to brain membranes: simultaneous measurement of D-1 and D-2 receptor sites.
    Morgan DG; Finch CE
    J Neurochem; 1986 May; 46(5):1623-31. PubMed ID: 2937884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [3H]SCH 23390 labels both dopamine-1 and 5-hydroxytryptamine1c receptors in the choroid plexus.
    Nicklaus KJ; McGonigle P; Molinoff PB
    J Pharmacol Exp Ther; 1988 Oct; 247(1):343-8. PubMed ID: 2971798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.